Skip to main content


The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.

What's new

Can more type 2 therapies be used for type 1 diabetes?  Continue Reading »

On September 12, Sanofi announced that it withdrew the FDA application for its once-daily GLP-1 agonist lixisenatide... Continue Reading »

Are all carbs created equal? Adam learns why 30 grams of carbs is NOT always 30 grams of carbs… Continue Reading »

A whole new approach to treating type 2 diabetes at diagnosis, a new type of metformin, and the benefit of adding a GLP-1 agonist to insulin. Continue Reading »

At ADA this year, type 2 drugs for type 1 diabetes show lots of promise. Plus, the latest exciting data on the Medtronic Veo and hypoglycemia. Continue Reading »